2026年全球智慧藥丸市場報告

近年來，智慧藥丸市場發展迅猛，預計將從2025年的61.1億美元成長到2026年的67.5億美元，複合年成長率達10.5%。過去幾年的成長可歸因於多種因素，例如慢性病盛行率的上升、對患者依從性監測需求的增加、數位醫療計劃的擴展、先進口腔感測器的廣泛應用及其在臨床研究中的日益普及。

預計未來幾年智慧藥丸市場規模將快速成長，到2030年將達到101.3億美元，複合年成長率（CAGR）為10.7%。預測期內的成長要素包括：對個人化醫療解決方案的需求不斷成長、對數位療法的投資增加、遠端患者監護的廣泛應用、智慧藥物輸送平台的日益普及以及對連線健診技術的監管支持力度加大。預測期內的主要趨勢包括：基於感測器的藥物傳輸系統應用日益廣泛、對藥物依從性解決方案的日益重視、與行動醫療平台的融合度不斷提高、智慧口腔診斷技術的擴展以及小型化電子設備的快速發展。

預計未來幾年，人們對無創技術的日益青睞將推動智慧藥丸市場的成長。無創技術無需切口或組織切除，從而降低患者風險並縮短恢復時間。非侵入性治療之所以備受青睞，是因為它們在提供有效診斷和治療效果的同時，最大限度地減輕了患者的身體負擔。智慧藥丸透過無需手術即可進行體內成像和生理監測，從而支持非侵入性治療，幫助臨床醫生透過這種簡單易吞服的裝置收集診斷資訊。例如，英國國家醫療服務體系（NHS）英格蘭分部於2024年3月報告稱，在53家醫療機構開展的結腸膠囊內視鏡（PillCam）試驗計畫中，已有超過5,400名患者受益。因此，人們對非侵入性治療方式日益青睞正在推動智慧藥丸市場的擴張。

預計未來幾年，不斷成長的醫療費用支出將推動智慧藥丸市場的發展。醫療費用支出是指用於醫療服務、治療、基礎設施、研究以及旨在維護和改善健康的公共衛生計畫的總支出。醫療費用支出的成長需求主要源自於慢性精神疾病盛行率的上升，這些疾病需要持續的治療、藥物和長期照護支援。醫療保健支出將透過資助創新技術來推動智慧藥丸的研發，這些創新技術能夠改善藥物輸送、監測功能並提高患者依從性。例如，根據美國聯邦機構醫療保險和醫療補助服務中心（CMS）的數據，預計到2023年，全國醫療保健支出（NHE）將成長7.5%，達到4.9兆美元，佔國內生產總值（GDP）的17.6%（截至2024年12月）。此外，預計2023年至2032年，全國平均醫療保健支出（NHE）將以每年5.6%的速度成長，醫療保健支出佔GDP的比例預計將從2022年的17.3%上升到2032年的19.7%。因此，不斷成長的醫療保健支出正在推動智慧藥丸市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球智慧藥丸市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 人工智慧（AI）和自主人工智慧
  • 物聯網、智慧基礎設施和互聯生態系統
  • 數位化、雲端運算、巨量資料、網路安全
  • 生物技術、基因組學和精準醫學
  • 工業4.0和智慧製造
• 主要趨勢
  • 感測器輔助藥物傳輸系統的應用日益普及
  • 人們越來越關注藥物依從性解決方案
  • 加強與行動醫療平台的整合
  • 拓展智慧口腔診斷
  • 加強小型電子設備的發展

第5章 終端用戶產業市場分析

• 醫院
• 診斷中心
• 研究所
• 製藥公司
• 數位醫療服務提供者

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球智慧藥丸市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球智慧藥丸市場規模、對比及成長率分析
• 全球智慧藥丸市場表現：規模與成長，2020-2025年
• 全球智慧藥丸市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 按學科領域
• 食道、胃、小腸、大腸
• 按疾病指徵
• 食道疾病、大腸疾病、小腸疾病及其他疾病適應症
• 透過使用
• 膠囊內視鏡、病患監測、藥物輸送
• 最終用戶
• 醫院、診斷中心和研究機構
• 按類型細分：食道
• 用於診斷食道疾病的膠囊，用於監測食道動力的膠囊
• 按類型細分：胃
• 用於監測排放的膠囊，用於診斷胃部疾病的膠囊
• 按類型分類的亞段：小腸
• 用於吸收測試的膠囊，用於診斷小腸疾病的膠囊
• 按類型分類的亞段：大腸
• 大腸鏡檢查替代膠囊，用於檢測結腸疾病的膠囊

第10章 區域與國家分析

• 全球智慧藥丸市場：區域分析、預測與趨勢（2020-2025年、2025-2030年預測、2035年預測）
• 全球智慧藥丸市場：按國家分類，實際結果和預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 智慧藥丸市場：競爭格局及市場佔有率（2024年）
• 智慧藥丸市場：公司估值矩陣
• 智慧藥丸市場：公司概況
  • Medtronic plc
  • Olympus Corporation
  • CapsoVision Inc.
  • Novartis AG
  • Proteus Digital Health Inc.

第37章：其他領先和創新企業

• Koninklijke Philips NV, MicroCHIPS Inc., Bio-Images Drug Delivery（BDD）Ltd., Given Imaging Ltd., Vitality Inc., Boston Scientific Corporation, HQ Inc., Fujifilm Holdings Corporation, General Electric Company, Check-Cap Ltd., IntroMedic Co. Ltd., Jinshan Science & Technology Co. Ltd., PENTAX Medical, etectRx Inc., Pixie Scientific HQ Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年智慧藥丸市場：提供新機會的國家
• 2030年智慧藥丸市場：蘊藏新機會的細分市場
• 2030年智慧藥丸市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Smart pills are designed for the purpose of administering medication and are equipped with electronic sensors that emit signals detectable by patches or smartphones upon ingestion. These innovative pills play a crucial role in ensuring patients' adherence to their prescribed drug regimens and enable the monitoring of medication compliance.

The primary applications of smart pills encompass capsule endoscopy, patient monitoring, and drug delivery. Patient monitoring involves the repeated or continuous tracking of various patient parameters. Smart pills are used to target specific areas within the gastrointestinal tract, including the esophagus, stomach, small intestine, and large intestine, for the treatment of conditions such as esophageal diseases, colon diseases, small bowel diseases, among others. These smart pills find utility in a variety of healthcare settings, including hospitals, diagnostic centers, and research institutes.

Tariffs are influencing the smart pills market by increasing costs of imported microelectronics, sensors, transmitters, and pharmaceutical-grade materials used in ingestible devices. Healthcare providers and research institutions in North America and Europe are most affected due to reliance on imported electronic components, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are raising development and production costs and slowing commercialization timelines. However, they are also encouraging localized electronics manufacturing, domestic R&D investments, and regional partnerships to advance smart pill innovation.

The smart pills market research report is one of a series of new reports from The Business Research Company that provides smart pills market statistics, including smart pills industry global market size, regional shares, competitors with a smart pills market share, detailed smart pills market segments, market trends and opportunities, and any further data you may need to thrive in the smart pills industry. This smart pills market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart pills market size has grown rapidly in recent years. It will grow from $6.11 billion in 2025 to $6.75 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, rising need for patient compliance monitoring, expansion of digital health initiatives, availability of advanced ingestible sensors, growing clinical research adoption.

The smart pills market size is expected to see rapid growth in the next few years. It will grow to $10.13 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing demand for personalized medicine solutions, rising investments in digital therapeutics, expansion of remote patient monitoring, growing adoption of smart drug delivery platforms, increasing regulatory support for connected health technologies. Major trends in the forecast period include increasing adoption of sensor-enabled drug delivery systems, rising focus on medication adherence solutions, growing integration with mobile health platforms, expansion of smart ingestible diagnostics, enhanced development of miniaturized electronics.

The increasing preference for non-invasive procedures is anticipated to drive the growth of the smart pills market in the coming years. Non-invasive procedures do not involve incisions or tissue removal, thereby reducing patient risk and shortening recovery time. The growing preference for non-invasive approaches is attributed to their ability to deliver effective diagnostic and therapeutic outcomes while minimizing physical burden on patients. Smart pills support non-invasive procedures by enabling internal imaging and physiological monitoring without the need for surgical entry, allowing clinicians to collect diagnostic information through a simple swallowable device. For example, in March 2024, according to NHS England, a UK-based public health service, more than 5,400 patients benefited from colon capsule endoscopy pill-cam pilot programs across 53 sites. Therefore, the rising preference for non-invasive procedures is contributing to the expansion of the smart pills market.

The increasing healthcare expenditure is anticipated to drive the growth of the smart pills market in the coming years. Healthcare expenditure refers to the overall spending on medical services, treatments, infrastructure, research, and public health programs aimed at maintaining or improving health outcomes. The rising demand for healthcare expenditure is attributed to the growing prevalence of chronic mental health conditions, which necessitate ongoing treatment, medication, and long-term care support. Healthcare expenditure facilitates the advancement of smart pills by financing innovative technologies that improve drug delivery, monitoring capabilities, and patient adherence. For example, in December 2024, according to the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, national health expenditures (NHE) increased by 7.5% to reach $4.9 trillion in 2023, representing 17.6% of gross domestic product (GDP). Furthermore, from 2023 to 2032, average national health expenditures (NHE) are expected to grow at an annual rate of 5.6%, leading to an increase in the healthcare spending share of GDP from 17.3% in 2022 to 19.7% in 2032. Thus, the rising healthcare expenditure is fueling the growth of the smart pills market.

Major companies operating in the smart pills market are concentrating on the development of smart pills with customizable programs, including ingestible multi-sensor prototypes that support tailored drug delivery and in-vivo monitoring to improve treatment adherence and therapeutic outcomes. Customizable programs refer to firmware- or software-based control of sensing functions, data collection, and triggerable actions that clinicians or trial managers can configure for individual patients. For example, in 2025, the Interuniversity Microelectronics Centre, a Belgium-based research and innovation institute, introduced a prototype ingestible sensor for gut health monitoring that integrates multiple sensing modalities chemical, mechanical, and electrical along with onboard signal processing, power management, and real-time data transmission for remote monitoring. The prototype focuses on miniaturization and full-system integration to enable configurable sensing programs for personalized clinical applications.

Major companies operating in the smart pills market are Medtronic plc, Olympus Corporation, CapsoVision Inc., Novartis AG, Proteus Digital Health Inc., Koninklijke Philips N.V., MicroCHIPS Inc., Bio-Images Drug Delivery (BDD) Ltd., Given Imaging Ltd., Vitality Inc., Boston Scientific Corporation, HQ Inc., Fujifilm Holdings Corporation, General Electric Company, Check-Cap Ltd., IntroMedic Co. Ltd., Jinshan Science & Technology Co. Ltd., PENTAX Medical, etectRx Inc., Pixie Scientific HQ Inc., ANX Robotica Corp., RF Co. Ltd., Shenzhen Jifu Medical Technology Co. Ltd., Otsuka America Pharmaceutical Inc., Medimetrics Personalized Drug Delivery B.V., Smart Pill Inc., Medisafe Inc., AdhereTech LLC, TabSafe Medical Services Inc.

North America was the largest region in the smart pills market in 2025. Western Europe was the second-largest region in the smart pills market analysis. The regions covered in the smart pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the smart pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The smart pills market consists of sales of instruments that are used in applications such as capsule endoscopy, drug delivery, and patient monitoring. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Pills Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses smart pills market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart pills ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart pills market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Target Area: Esophagus; Stomach; Small Intestine; Large Intestine
• 2) By Disease Indication: Esophageal Diseases; Colon Diseases; Small bowel Diseases; And Other Disease Indications
• 3) By Application: Capsule Endoscopy; Patient Monitoring; Drug Delivery
• 4) By End User: Hospital; Diagnostic Center; Research Institute
• Subsegments:
• 1) By Esophagus: Diagnostic Pills For Esophageal Disorders; Pills For Monitoring Esophageal Motility
• 2) By Stomach: Gastric Emptying Monitoring Pills; Diagnostic Pills For Gastric Disorders
• 3) By Small Intestine: Pills For Absorption Studies; Diagnostic Pills For Small Bowel Diseases
• 4) By Large Intestine: Colonoscopy Alternative Pills; Pills For Detecting Colorectal Disorders
• Companies Mentioned: Medtronic plc; Olympus Corporation; CapsoVision Inc.; Novartis AG; Proteus Digital Health Inc.; Koninklijke Philips N.V.; MicroCHIPS Inc.; Bio-Images Drug Delivery (BDD) Ltd.; Given Imaging Ltd.; Vitality Inc.; Boston Scientific Corporation; HQ Inc.; Fujifilm Holdings Corporation; General Electric Company; Check-Cap Ltd.; IntroMedic Co. Ltd.; Jinshan Science & Technology Co. Ltd.; PENTAX Medical; etectRx Inc.; Pixie Scientific HQ Inc.; ANX Robotica Corp.; RF Co. Ltd.; Shenzhen Jifu Medical Technology Co. Ltd.; Otsuka America Pharmaceutical Inc.; Medimetrics Personalized Drug Delivery B.V.; Smart Pill Inc.; Medisafe Inc.; AdhereTech LLC; TabSafe Medical Services Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Smart Pills Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Smart Pills Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Smart Pills Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Smart Pills Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Biotechnology, Genomics & Precision Medicine
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Sensor-Enabled Drug Delivery Systems
  • 4.2.2 Rising Focus On Medication Adherence Solutions
  • 4.2.3 Growing Integration With Mobile Health Platforms
  • 4.2.4 Expansion Of Smart Ingestible Diagnostics
  • 4.2.5 Enhanced Development Of Miniaturized Electronics

5. Smart Pills Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Centers
• 5.3 Research Institutes
• 5.4 Pharmaceutical Companies
• 5.5 Digital Health Providers

6. Smart Pills Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Smart Pills Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Smart Pills PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Smart Pills Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Smart Pills Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Smart Pills Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Smart Pills Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Smart Pills Market Segmentation

• 9.1. Global Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Esophagus, Stomach, Small Intestine, Large Intestine
• 9.2. Global Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Esophageal Diseases, Colon Diseases, Small Bowel Diseases, Other Disease Indications
• 9.3. Global Smart Pills Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Capsule Endoscopy, Patient Monitoring, Drug Delivery
• 9.4. Global Smart Pills Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital, Diagnostic Center, Research Institute
• 9.5. Global Smart Pills Market, Sub-Segmentation Of Esophagus, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostic Pills For Esophageal Disorders, Pills For Monitoring Esophageal Motility
• 9.6. Global Smart Pills Market, Sub-Segmentation Of Stomach, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gastric Emptying Monitoring Pills, Diagnostic Pills For Gastric Disorders
• 9.7. Global Smart Pills Market, Sub-Segmentation Of Small Intestine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pills For Absorption Studies, Diagnostic Pills For Small Bowel Diseases
• 9.8. Global Smart Pills Market, Sub-Segmentation Of Large Intestine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Colonoscopy Alternative Pills, Pills For Detecting Colorectal Disorders

10. Smart Pills Market Regional And Country Analysis

• 10.1. Global Smart Pills Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Smart Pills Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Smart Pills Market

• 11.1. Asia-Pacific Smart Pills Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Smart Pills Market

• 12.1. China Smart Pills Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Smart Pills Market

• 13.1. India Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Smart Pills Market

• 14.1. Japan Smart Pills Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Smart Pills Market

• 15.1. Australia Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Smart Pills Market

• 16.1. Indonesia Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Smart Pills Market

• 17.1. South Korea Smart Pills Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Smart Pills Market

• 18.1. Taiwan Smart Pills Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Smart Pills Market

• 19.1. South East Asia Smart Pills Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Smart Pills Market

• 20.1. Western Europe Smart Pills Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Smart Pills Market

• 21.1. UK Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Smart Pills Market

• 22.1. Germany Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Smart Pills Market

• 23.1. France Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Smart Pills Market

• 24.1. Italy Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Smart Pills Market

• 25.1. Spain Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Smart Pills Market

• 26.1. Eastern Europe Smart Pills Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Smart Pills Market

• 27.1. Russia Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Smart Pills Market

• 28.1. North America Smart Pills Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Smart Pills Market

• 29.1. USA Smart Pills Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Smart Pills Market

• 30.1. Canada Smart Pills Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Smart Pills Market

• 31.1. South America Smart Pills Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Smart Pills Market

• 32.1. Brazil Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Smart Pills Market

• 33.1. Middle East Smart Pills Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Smart Pills Market

• 34.1. Africa Smart Pills Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Smart Pills Market Regulatory and Investment Landscape

36. Smart Pills Market Competitive Landscape And Company Profiles

• 36.1. Smart Pills Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Smart Pills Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Smart Pills Market Company Profiles
  • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. CapsoVision Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Proteus Digital Health Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Smart Pills Market Other Major And Innovative Companies

• Koninklijke Philips N.V., MicroCHIPS Inc., Bio-Images Drug Delivery (BDD) Ltd., Given Imaging Ltd., Vitality Inc., Boston Scientific Corporation, HQ Inc., Fujifilm Holdings Corporation, General Electric Company, Check-Cap Ltd., IntroMedic Co. Ltd., Jinshan Science & Technology Co. Ltd., PENTAX Medical, etectRx Inc., Pixie Scientific HQ Inc.

38. Global Smart Pills Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Smart Pills Market

40. Smart Pills Market High Potential Countries, Segments and Strategies

• 40.1 Smart Pills Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Smart Pills Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Smart Pills Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer